Clinical Trials Browser

Neoplasms, Prostatic Neoplasms

Carcinoma, Renal Cell

Urinary Bladder Neoplasms, Prostatic Neoplasms

Adenocarcinoma, Erectile Dysfunction, Prostatic Neoplasms

Disease, Prostatic Neoplasms

Prostatic Neoplasms

Disease, Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Locally Advanced or Metastatic Urothelial Cancer

Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Transitional Cell

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Neoplasm Metastasis, Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Prostatic Neoplasms, Neoplasm, Residual

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Adenocarcinoma, Prostatic Neoplasms

Kidney Neoplasms

Bladder Cancer Cell Transitional

Aortic Diseases, Liver Neoplasms, Prostatic Neoplasms, Thrombosis, Myocardial Ischemia

Prostatic Neoplasms

Disease, Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

Metastatic Hormonesensitive Prostate Cancer (mHSPC)

Prostatic Neoplasms

Advanced Bladder Cancer

Urinary Bladder Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Metastatic Hormone-Sensitive Prostate Cance

Disease, Prostatic Neoplasms

Prostatic Neoplasms

Neoplasms, Prostatic Neoplasms

Carcinoma, Transitional Cell

Kidney Neoplasms

Urinary Bladder Neoplasms, Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Carcinoma, Hepatocellular, Prostatic Neoplasms

Metastatic Hormone-sensitive Prostate Cancer

Carcinoma, Renal Cell, Kidney Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms

Prostatic Neoplasms

Carcinoma, Transitional Cell, Hematuria

Prostatic Neoplasms

Prostatic Neoplasms

Wilms Tumor, Neuroblastoma, Purpura, Thrombocytopenic, Idiopathic

Clinical Trials

CHAS3

RASROP-003

UroDNA

PRIAPUS-PCa

PROSTest_STRAT

VAPOR-LTR

CLEAR-PC

TransPRIDE

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

ARON-2PLUS

SEQ-bpMRI

INCLUDE PC

A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer

Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer

PR3DICT

ROAD

Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

ENAiBLE

TA-P-OLIM

AI for Renal Tumors Using Non-Contrast CT

SARC-NMIBC

Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy

FOLLOW-UP

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

NEUTROFLOW

TARA

RWS-GU001

γδ-T-BLADDER

AssiutU

CHLOECAPA

ultraHART

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

PREDICT

NEWPROMRI

PROSPEX

Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy

RUPTURE

Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy

Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy

LOCUS

Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer

KIDCaD

PREduKiné

SR-ULM BC

High-resolution Intra-operative PSMA PET-CT in Prostate Cancer

UMT-UC

Focal Laser Ablation in Prostate Cancer

Prostate Specific Antigen Levels of Individuals Living in Rural Areas

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China